To further explore the prognostic value of EIF4EBP1, we used the online tool http://gepia.cancer-pku.cn/ and the result showed that the overall survival of AML patients with higher EIF4EBP1 expression was significantly poorer than those with lower EIF4EBP1 expression (Fig. 5c). This evidence concerns the gene EIF4EBP1 and acute myeloid leukemia.